An on-demand webinar by Certara details how pharmaceutical companies can streamline their drug development process. Although gene therapy treatments are often accelerated due to unmet patient needs, post-clinical success and market access remain challenging. Speakers include Dr. Emily Jean Woodward, Director of the Customer Engagement group, and Dr. Maximilian Vargas, Senior Director, US Access Strategy and Account Management at Certara.
“To avoid commercial disappointment, clinical strategy, regulatory and commercial executives must operate in tight alignment, addressing various hurdles leading up to ultimate product success in the real world. Commercial GT leaders are thus expected to engage early and often in product development and regulatory strategy. In this session, experts from the leading drug development platform Certara offer a case-study and best-practice-driven tutorial to help them streamline, accelerate and de-risk clinical development for GT.” Learn more here.
(Source: Certara, 2021)